Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors for Treatment of Breast Cancer in Egypt

by | Mar 23, 2026 | Clinical Trials | 0 comments

​ Conditions: Breast Cancer

Interventions: Drug: Palbocicilib; Drug: Ribociclib; Drug: Abemaciclib

Sponsors: Beni-Suef University

Completed Conditions: Breast Cancer
Interventions: Drug: Palbocicilib; Drug: Ribociclib; Drug: Abemaciclib
Sponsors: Beni-Suef University
Completed 

Submit a Comment

Your email address will not be published. Required fields are marked *